ALBO
Albireo Pharma Inc
$44.15
Earnings Summary
Revenue | $9.83Mn |
Net Profits | $-37.8Mn |
Net Profit Margins | -384.46% |
Highlights
Albireo Pharma Inc’s revenue jumped 168.34% since last year same period to $9.83Mn in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 19.81% jump in its revenue since last 3-months.
Albireo Pharma Inc’s net profit fell -166.22% since last year same period to $-37.8Mn in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 5.38% jump in its net profits since last 3-months.
Albireo Pharma Inc’s net profit margin fell -124.68% since last year same period to -384.46% in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 21.03% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Albireo Pharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.83 |
EPS Estimate Current Year | -1.83 |
Highlights
Albireo Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -1.83 - a -72.64% fall from last quarter’s estimates.
Albireo Pharma Inc’s earning per share (EPS) estimates for the current year stand at -1.83.
Key Ratios
Key ratios of the Albireo Pharma Inc post its Q3 2022 earnings
Earning Per Share (EPS) | -1.92 |
Highlights
Albireo Pharma Inc’s earning per share (EPS) fell -166.21% since last year same period to -1.92 in the Q3 2022. This indicates that the Albireo Pharma Inc has generated -166.21% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-08 | -1.06 | -1.92 | -81.13% |
2022-05-16 | -1.85 | -2.19 | -18.38% |
2022-08-15 | -1.65 | -2.04 | -23.64% |
₹0 US Stocks a/c Opening Fee